1Pardridge W M. Drug targeting to the brain [ J]. Pharm Res, 2007,24 (9) : 1733-1744.
2Garcia E, Andrieux K, Gil S, et al. Colloidal carriers and blood-brain battier (BBB) translocation : A way to deliver drugs to the brain? [J]. Int J Pharm, 2005,298 (2) : 274-292.
3Hau P, Fabeli K, Baumgart U, et al. Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma[ J]. Cancer, 2004, 100(6) : 1199-1207.
4Huwyler J, Wu D F, Pardridge W M. Brain drug delivery of small molecules using immunoliposomes[Jl. Proc Natl Acad Sci USA, 1996, 93(24) : 14164-14169.
5Yoshida J, Mizuno M,Fujii M,et al. Human gene therapy for malignant gliomas( glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes [J]. Hum Gene Ther,2004,15( 1) :77-86.
6Corine C V, Sanja S, Heleen L V, et al. Targeting liposomes with protein drugs to the blood-brain barrier in vitro [J].Euro J Pharm Sci,2005,25 (2-3) :299-305.
7Jones A R, Shusta E V. Blood-brain barrier transport of therapeutics via receptor- mediation [ J ]. Pharm Res, 2007,24 (9) : 1759-1771.
8Qin J, Chen D W, Hu H Y, et al. Surface modification of RGD-liposome for selective drug delivery to monocytes/neutrophils in brain [ J]. Chem Pharm Bull, 2007,55 (8) : 1192-1197.
9Jain S, Mishra V, Singh P. RGD-anchored magnetic liposomes tbr monocytes/neutrophils mediated brain targeting[J]. Int J Pharm, 2003,261 (1-2) :43-55.
10Begley D J. Delivery of therapeutic agents to the central nervous system : the problems and the possibilities [ J ]. Pharmacol Ther, 2004,104 ( 1) : 29-45.
5LAWRENCE M J,REES G D.Microemulsion-based media as novel drug delivery systems[J].Adv Drug Deliv Rev,2000,45:89-121.
6ZHANG Q Z,JIANG X G,JIANG W M,et al.Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain[J].Int J Pharm,2004,275:85 -96.
7TONG X Y,HUANG C Y,YAO J,et al.Distribution of nimodipine microemulsion in mice in vivo and evaluation on its targeting performance[J].J China Pharm University,2002,33 (4):293-296.
8YAO J,ZHOU J P,LU Y,et al.Effect of Cremophor-based microemulsion on the permeablility of blood brain barrier[J].J China Pharm University,2005,36(1):27-30.
9KLEYMANN G.Agents and strategies in development for improved management of herpes simplex virus infection and disease[J].Expert Upin Investig Drugs,2005,14 (2):135-161.
10WANG J X,SUN X,ZHANG Z R.Enhanced brain targeting by systhesis of 3',5 ' -dioctanoyl-5-fluoro-2' -deoxyuridine and incorporation into solid lipid naoparticles[J].Eur J Pharm Biopharm,2002,54:285 -290.
8Schmidt-Wolf I G,Lefterova P,Johnston V,et al.Propagation of large numbers of T cells with natural killer cell markers[J].Br J Haematol,1994,87(3):453-458.
9Segal D M,Weiner G J,Weiner L M.Bispecific antibodies in cancer therapy[J].Curr Opin Immunol,1999,11:558-562.
10Mehta B A,Schmidt-Wolf I G,Weissman I L,et al.Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells[J].Blood,1995,86:3493-3499.
